NUDT15 and inflammatory bowel disease: The prevalence of identified mutations in our study group—especially the very low frequency noted for the NUDT15*3 variant and the limited number of meaningful associations found—constrains the potential to make definitive conclusions regarding the relevance of TMTP and NUDT15 testing in our Italian population of IBD patients.